Just read again Michael Boyd's updates on Jayex at the AGM late July and interestingly notice the following sentences (which I overlooked when first reading it):
"In June this year, we entered into a Software Licence Agreement with Lifespot Health Ltd for technologies which allow patients to monitor chronic disease and critical conditions with their mobile device. The data can be shared in real-time with healthcare professionals allowing for conditions such as chronic diseases, post-operative recovery and COVID-19 to be monitored remotely.
We have valued this “home care” and “RPM” service at $12 billion across the UK, Australian and New Zealand markets."
It seems they are going to integrate something related to covid19 monitoring into their platform, but there has not been any update about this. Anyone knows this or any insight? I guess it would have a significant impact if they can update the progress about this in the coming HY report.
Jayex and Covid-19?
-
- There are more pages in this discussion • 41 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
